Batoclimab

Batoclimab
Monoclonal antibody
Type?
Identifiers
CAS Number
UNII

Batoclimab (also known as HBM9161 or HL161) is a fully human monoclonal antibody administered by subcutaneous injection. It works by inhibiting the neonatal fragment crystallizable receptor, which leads to a reduction in antibodies of the thyrotropin receptor. It is being developed to treat myasthenia gravis and thyroid eye disease.[1][2][3]

References

  1. ^ Kahaly, George J.; Dolman, Peter J.; Wolf, Jan; Giers, Bert C.; Elflein, Heike M.; Jain, Amy P.; Srinivasan, Ashok; Hadjiiski, Lubomir; Jordan, David; Bradley, Elizabeth A.; Stan, Marius N.; Eckstein, Anja; Pitz, Susanne; Vorländer, Christian; Wester, Sara T.; Nguyen, John; Tucker, Nancy; Sales-Sanz, Marco; Feldon, Steven E.; Nelson, Christine C.; Hardy, Isabelle; Abia-Serrano, Maravillas; Tedeschi, Philip; Janes, Jonathan M.; Xu, Jing; Vue, Peter; Macias, William L.; Douglas, Raymond S. (30 June 2023). "Proof-of-Concept and Randomized, Placebo-Controlled Trials of an Fcrn Inhibitor, Batoclimab, for Thyroid Eye Disease". The Journal of Clinical Endocrinology and Metabolism. 108 (12): 3122–3134. doi:10.1210/clinem/dgad381. ISSN 1945-7197. PMC 10655547. PMID 37390454. S2CID 259303423.
  2. ^ Yan, Chong; Duan, Rui-Sheng; Yang, Huan; Li, Hai-Feng; Zou, Zhangyu; Zhang, Hua; Zhou, Hongyu; Li, Xiao-Li; Zhou, Hao; Jiao, Lidong; Chen, Jialin; Yin, Jian; Du, Qin; Lee, Michael; Chen, Yu; Chen, Xiaoxiang; Zhao, Chongbo (June 2022). "Therapeutic Effects of Batoclimab in Chinese Patients with Generalized Myasthenia Gravis: A Double-Blinded, Randomized, Placebo-Controlled Phase II Study". Neurology and Therapy. 11 (2): 815–834. doi:10.1007/s40120-022-00345-9. PMC 9095773. PMID 35412216.
  3. ^ Yap, Desmond Y. H.; Hai, Jojo; Lee, Paul C. H.; Zhou, Xueying; Lee, Michael; Zhang, Yu; Wang, Meng; Chen, Xiaoxiang (September 2021). "Safety, tolerability, pharmacokinetics, and pharmacodynamics of HBM9161, a novel FcRn inhibitor, in a phase I study for healthy Chinese volunteers". Clinical and Translational Science. 14 (5): 1769–1779. doi:10.1111/cts.13019. PMC 8504844. PMID 33742786.{{cite journal}}: CS1 maint: unflagged free DOI (link)
Stub icon

This monoclonal antibody–related article is a stub. You can help Wikipedia by adding missing information.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.